{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:17:22Z","timestamp":1744085842875,"version":"3.40.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bbr.2012.08.034","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T02:46:04Z","timestamp":1346121964000},"page":"30-34","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Individual phenotype predicts nicotine-haloperidol interaction in catalepsy: Possible implication for the therapeutic efficacy of nicotine in Tourette's syndrome"],"prefix":"10.1016","volume":"236","author":[{"given":"Sandra M.","family":"Boye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2012.08.034_bib0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment and pharmacotherapy of Tourette syndrome","volume":"3","author":"Scahill","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbr.2012.08.034_bib0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.bbr.2012.08.034_bib0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0006-3223(92)90315-Q","article-title":"The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder","volume":"31","author":"McConville","year":"1992","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.08.034_bib0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(88)91388-8","article-title":"Nicotine gum and haloperidol in Tourette's syndrome","volume":"1","author":"Sanberg","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2012.08.034_bib0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0140-6736(93)91392-Y","article-title":"Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome","volume":"342","author":"Silver","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2012.08.034_bib0030","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(94)90388-3","article-title":"Longlasting improvement of Tourette's syndrome with transdermal nicotine","volume":"344","author":"Dursun","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2012.08.034_bib0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/284472a0","article-title":"Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors","volume":"284","author":"Sanberg","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2012.08.034_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0753-3322(89)90186-8","article-title":"Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome","volume":"43","author":"Sanberg","year":"1989","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.1016\/j.bbr.2012.08.034_bib0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0091-3057(91)90256-2","article-title":"Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity","volume":"38","author":"Emerich","year":"1991","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.bbr.2012.08.034_bib0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0022-3565(25)22152-8","article-title":"Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats","volume":"246","author":"Clarke","year":"1988","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2012.08.034_bib0055","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/jpet.111.189100","article-title":"Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats","volume":"340","author":"Bordia","year":"2012","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2012.08.034_bib0060","first-page":"385","article-title":"Nicotine potentiates the behavioral effects of haloperidol","volume":"27","author":"Emerich","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.bbr.2012.08.034_bib0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0091-3057(93)90357-Y","article-title":"Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms","volume":"46","author":"Sanberg","year":"1993","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.bbr.2012.08.034_bib0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1098-2299(199906)47:2<90::AID-DDR4>3.0.CO;2-5","article-title":"Mutually potentiating effects of mecamylamine and haloperidol in producing catalepsy in rats","volume":"47","author":"Levin","year":"1999","journal-title":"Drug Development Research"},{"key":"10.1016\/j.bbr.2012.08.034_bib0075","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1139\/y00-070","article-title":"Enhancement of haloperidol-induced catalepsy by nicotine: an investigation of possible mechanisms","volume":"78","author":"Boye","year":"2000","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.bbr.2012.08.034_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002130050992","article-title":"Stress reinstates nicotine seeking but not sucrose solution seeking in rats","volume":"144","author":"Buczek","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.08.034_bib0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF02253543","article-title":"Acute stress or corticosterone administration reduces responsiveness to nicotine: implications for a mechanism of conditioned tolerance","volume":"111","author":"Caggiula","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.08.034_bib0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1037\/0735-7044.121.3.550","article-title":"Intracranial self-stimulation of the dorsal raphe sensitizes psychostimulant locomotion","volume":"121","author":"Boye","year":"2007","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2012.08.034_bib0095","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.2781295","article-title":"Factors that predict individual vulnerability to amphetamine self-administration","volume":"245","author":"Piazza","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbr.2012.08.034_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/syn.890090206","article-title":"Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine","volume":"9","author":"Hooks","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2012.08.034_bib0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-8993(93)91451-W","article-title":"Individual differences in the psychomotor effects of morphine are predicted by reactivity to novelty and influenced by corticosterone secretion","volume":"623","author":"Deroche","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.08.034_bib0110","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1073\/pnas.88.6.2088","article-title":"Corticosterone levels determine individual vulnerability to amphetamine self-administration","volume":"88","author":"Piazza","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2012.08.034_bib0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002130100867","article-title":"Locomotor response to novelty predicts a rat's propensity to self-administer nicotine","volume":"158","author":"Suto","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.08.034_bib0120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0306-4522(93)90144-5","article-title":"Modulation of the locomotor response to amphetamine by corticosterone","volume":"56","author":"Cador","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.08.034_bib0125","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1073\/pnas.93.16.8716","article-title":"Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission","volume":"93","author":"Piazza","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2012.08.034_bib0130","doi-asserted-by":"crossref","first-page":"15445","DOI":"10.1073\/pnas.93.26.15445","article-title":"Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission","volume":"93","author":"Piazza","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2012.08.034_bib0135","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0924-9338(96)88392-1","article-title":"The efficacy of a dose-escalated application of transdermal nicotine plus sulpiride in Tourette's syndrome","volume":"11","author":"Dursun","year":"1996","journal-title":"European Psychiatry"},{"key":"10.1016\/j.bbr.2012.08.034_bib0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02245149","article-title":"The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine","volume":"107","author":"Corrigall","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.08.034_bib0145","first-page":"233","article-title":"Haloperidol-induced catalepsy is influenced by calcium channel antagonists","volume":"57","author":"Biala","year":"2000","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"10.1016\/j.bbr.2012.08.034_bib0150","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0090-9556(24)14955-0","article-title":"Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2\u2032-(14)C]nicotine","volume":"27","author":"Ghosheh","year":"1999","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.bbr.2012.08.034_bib0155","first-page":"47","article-title":"Metabolites of nicotine in rat brain after peripheral nicotine administration","volume":"25","author":"Crooks","year":"1997","journal-title":"Cotinine, Nornicotine, and Norcotinine. Drug Metab Disposition."},{"key":"10.1016\/j.bbr.2012.08.034_bib0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00207450108986527","article-title":"Mecamylamine effects on haloperidol-induced catalepsy defecation","volume":"109","author":"Sanberg","year":"2001","journal-title":"International Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2012.08.034_bib0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(05)60822-7","article-title":"Treatment of Tourette's syndrome with mecamylamine","volume":"352","author":"Sanberg","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2012.08.034_bib0170","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0278-5846(00)00178-0","article-title":"Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat","volume":"25","author":"Newman","year":"2001","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.08.034_bib0175","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/00004583-199612000-00015","article-title":"Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome","volume":"35","author":"Silver","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.bbr.2012.08.034_bib0180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1098-2299(199607\/08)38:3\/4<290::AID-DDR18>3.0.CO;2-2","article-title":"Transdermal nicotine for Tourette's syndrome","volume":"38","author":"Shytle","year":"1996","journal-title":"Drug Development Research"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812005608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812005608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T10:21:46Z","timestamp":1744021306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432812005608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":36,"alternative-id":["S0166432812005608"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2012.08.034","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}